Monday, June 29, 2009

Cryolife - Bioglue Hits 500,000 Procedure Milestone

CryoLife, Inc., (NYSE: CRY) an implantable biological medical device and cardiovascular tissue processing company, today announced that, according to company data, CryoLife's BioGlue(R) Surgical Adhesive has been used in more than 500,000 surgical procedures throughout the world since its introduction into the international market in 1998 and in the United States in 2001. BioGlue is a leading surgical adhesive used in cardiovascular surgeries worldwide.
This link will give you the IFU for BioGlue® Surgical Adhesive (BioGlue).

No comments: